Table 3.
Characteristics | (n = 127) |
---|---|
Median age, years (range) | 46 (30–69) |
Gender, n | |
Male | 127 |
Female | 0 |
Hospital type, n | |
Government | 27 |
University | 33 |
Private | 41 |
Clinic | 20 |
Advanced cancer care hospital, n | |
Yes | 64 |
No | 63 |
Median clinical experience after medical internship, years (range) | 20 (5–40) |
Hospital department, n | |
Urology | 127 |
Other | 0 |
Average number of PCa patients on treatment (± SD) | 111 (± 130) |
Average number of CRPC patients on treatment (± SD) | 13 (± 13) |
Prescribing experience, n (yes/no) | |
Enzalutamide | 101/26 |
Abiraterone acetate | 83/44 |
Docetaxel | 74/53 |
Cabazitaxel | 32/95 |
Note. CRPC = castration-resistant prostate cancer; PCa = prostate cancer.